hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders
Cells · 2024
DOI: 10.3390/cells13110903 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Vukasin M Jovanovic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Translation Laboratory (SCTL), Division of Preclinical Innovation (DPI), National Center for Advancing Translational Sciences (NCATS), NIH,…. Hauptthemen laut MEDLINE: Astrocytes, Nervous System Diseases, Cell Differentiation, Pluripotent Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH Intramural Research Program, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH).
Abstract (Originalsprache)
Astrocytes, the most abundant glial cell type in the brain, play crucial roles in maintaining homeostasis within the central nervous system (CNS). Impairment or abnormalities of typical astrocyte functions in the CNS serve as a causative or contributing factor in numerous neurodevelopmental, neurodegenerative, and neuropsychiatric disorders. Currently, disease-modeling and drug-screening approaches, primarily focused on human astrocytes, rely on human pluripotent stem cell (hPSC)-derived astrocytes. However, it is important to acknowledge that these hPSC-derived astrocytes exhibit notable differences across studies and when compared to their in vivo counterparts. These differences may potentially compromise translational outcomes if not carefully accounted for. This review aims to explore state-of-the-art in vitro models of human astrocyte development, focusing on the developmental processes, functional maturity, and technical aspects of various hPSC-derived astrocyte differentiation protocols. Additionally, it summarizes their successful application in modeling neurological disorders. The discussion extends to recent advancements in the large-scale production of human astrocytes and their application in developing high-throughput assays conducive to therapeutic drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cell Translation Laboratory (SCTL), Division of Preclinical Innovation (DPI), National Center for Advancing Translational Sciences (NCATS), NIH, Rockville, MD 20850, USA.
ORCID-Profile: Vukasin M Jovanovic
Förderung
- NIH Intramural Research Program
- National Center for Advancing Translational Sciences (NCATS)
- National Institutes of Health (NIH)
Zitieren
APA
Jovanovic, V. M., Mesch, K. T., & Tristan, C. A. (2024). hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders. Cells. https://doi.org/10.3390/cells13110903
Vancouver
Jovanovic VM, Mesch KT, Tristan CA. hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders. Cells. 2024. doi:10.3390/cells13110903
BibTeX
@article{Jovanovic2024,
author = {Jovanovic, Vukasin M and Mesch, Kendall T and Tristan, Carlos A},
title = {hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13110903}
}
EUVIMED